Bio-Rad Laboratories PE Ratio 2012-2025 | BIO
Current and historical p/e ratio for Bio-Rad Laboratories (BIO) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bio-Rad Laboratories PE ratio as of February 12, 2026 is 29.48.
| Bio-Rad Laboratories PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-02-13 | 256.56 | 0.00 | |
| 2025-09-30 | 280.39 | $-24.31 | 0.00 |
| 2025-06-30 | 241.32 | $11.73 | 20.57 |
| 2025-03-31 | 243.56 | $-76.20 | 0.00 |
| 2024-12-31 | 328.51 | $-65.04 | 0.00 |
| 2024-09-30 | 334.58 | $-27.33 | 0.00 |
| 2024-06-30 | 273.11 | $-47.03 | 0.00 |
| 2024-03-31 | 345.87 | $-10.36 | 0.00 |
| 2023-12-31 | 322.89 | $-21.49 | 0.00 |
| 2023-09-30 | 358.45 | $-5.85 | 0.00 |
| 2023-06-30 | 379.12 | $-15.01 | 0.00 |
| 2023-03-31 | 479.02 | $-6.54 | 0.00 |
| 2022-12-31 | 420.49 | $-121.43 | 0.00 |
| 2022-09-30 | 417.14 | $-201.80 | 0.00 |
| 2022-06-30 | 495.00 | $-66.32 | 0.00 |
| 2022-03-31 | 563.23 | $-4.88 | 0.00 |
| 2021-12-31 | 755.57 | $140.07 | 5.39 |
| 2021-09-30 | 745.95 | $220.47 | 3.38 |
| 2021-06-30 | 644.29 | $134.15 | 4.80 |
| 2021-03-31 | 571.17 | $135.98 | 4.20 |
| 2020-12-31 | 582.94 | $126.32 | 4.61 |
| 2020-09-30 | 515.46 | $116.82 | 4.41 |
| 2020-06-30 | 451.49 | $64.50 | 7.00 |
| 2020-03-31 | 350.56 | $52.21 | 6.71 |
| 2019-12-31 | 370.03 | $58.23 | 6.35 |
| 2019-09-30 | 332.74 | $12.04 | 27.64 |
| 2019-06-30 | 312.59 | $29.61 | 10.56 |
| 2019-03-31 | 305.68 | $18.62 | 16.42 |
| 2018-12-31 | 232.22 | $11.65 | 19.93 |
| 2018-09-30 | 312.99 | $41.85 | 7.48 |
| 2018-06-30 | 288.54 | $33.87 | 8.52 |
| 2018-03-31 | 250.08 | $25.17 | 9.94 |
| 2017-12-31 | 238.67 | $3.81 | 62.64 |
| 2017-09-30 | 222.22 | $0.79 | 281.29 |
| 2017-06-30 | 226.31 | $0.50 | 452.62 |
| 2017-03-31 | 199.34 | $0.94 | 212.06 |
| 2016-12-31 | 182.28 | $0.95 | 191.87 |
| 2016-09-30 | 163.81 | $3.33 | 49.19 |
| 2016-06-30 | 143.02 | $3.30 | 43.34 |
| 2016-03-31 | 136.72 | $3.66 | 37.36 |
| 2015-12-31 | 138.66 | $3.85 | 36.02 |
| 2015-09-30 | 134.31 | $3.51 | 38.26 |
| 2015-06-30 | 150.61 | $3.31 | 45.50 |
| 2015-03-31 | 135.18 | $3.43 | 39.41 |
| 2014-12-31 | 120.56 | $3.05 | 39.53 |
| 2014-09-30 | 113.40 | $2.75 | 41.24 |
| 2014-06-30 | 119.71 | $2.11 | 56.73 |
| 2014-03-31 | 128.12 | $2.22 | 57.71 |
| 2013-12-31 | 123.61 | $2.67 | 46.30 |
| 2013-09-30 | 117.56 | $3.28 | 35.84 |
| 2013-06-30 | 112.20 | $5.01 | 22.40 |
| 2013-03-31 | 126.00 | $5.50 | 22.91 |
| 2012-12-31 | 105.05 | $5.91 | 17.77 |
| 2012-09-30 | 106.72 | $6.34 | 16.83 |
| 2012-06-30 | 100.01 | $6.47 | 15.46 |
| 2012-03-31 | 103.69 | $6.19 | 16.75 |
| 2011-12-31 | 96.04 | $6.26 | 15.34 |
| 2011-09-30 | 90.77 | $6.59 | 13.77 |
| 2011-06-30 | 119.36 | $6.57 | 18.17 |
| 2011-03-31 | 120.14 | $6.51 | 18.45 |
| 2010-12-31 | 103.85 | $6.59 | 15.76 |
| 2010-09-30 | 90.51 | $5.53 | 16.37 |
| 2010-06-30 | 86.49 | $5.32 | 16.26 |
| 2010-03-31 | 103.52 | $5.34 | 19.39 |
| 2009-12-31 | 96.46 | $5.20 | 18.55 |
| 2009-09-30 | 91.88 | $3.55 | 25.88 |
| 2009-06-30 | 75.48 | $3.18 | 23.74 |
| 2009-03-31 | 65.90 | $3.39 | 19.44 |
| 2008-12-31 | 75.31 | $3.25 | 23.17 |
| 2008-09-30 | 99.12 | $4.00 | 24.78 |
| 2008-06-30 | 80.89 | $4.02 | 20.12 |
| 2008-03-31 | 88.95 | $3.39 | 26.24 |
| 2007-12-31 | 103.62 | $3.42 | 30.30 |
| 2007-09-30 | 90.50 | $3.58 | 25.28 |
| 2007-06-30 | 75.57 | $3.41 | 22.16 |
| 2007-03-31 | 69.84 | $3.66 | 19.08 |
| 2006-12-31 | 82.52 | $3.83 | 21.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.888B | $2.583B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.832B | 21.65 |
| EssilorLuxottica (ESLOY) | France | $143.666B | 0.00 |
| Stryker (SYK) | United States | $140.007B | 26.84 |
| Medtronic (MDT) | Ireland | $129.330B | 17.92 |
| Boston Scientific (BSX) | United States | $109.879B | 24.30 |
| Medline (MDLN) | United States | $58.579B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.565B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.845B | 17.17 |
| ResMed (RMD) | United States | $35.798B | 23.90 |
| Agilent Technologies (A) | United States | $35.321B | 22.38 |
| Koninklijke Philips (PHG) | Netherlands | $30.245B | 17.95 |
| Terumo (TRUMY) | Japan | $19.677B | 22.23 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.863B | 11.61 |
| Insulet (PODD) | United States | $16.941B | 52.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.096B | 0.00 |
| Baxter (BAX) | United States | $9.618B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.731B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $4.557B | 13.88 |
| BillionToOne (BLLN) | United States | $4.105B | 0.00 |
| ICU Medical (ICUI) | United States | $3.506B | 22.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.168B | 14.95 |
| Haemonetics (HAE) | United States | $2.679B | 11.72 |
| Neogen (NEOG) | United States | $2.345B | 51.33 |
| Phibro Animal Health (PAHC) | United States | $2.078B | 18.31 |
| Perrigo (PRGO) | Ireland | $1.979B | 4.96 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.54 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.612B | 11.20 |
| Kestra Medical Technologies (KMTS) | United States | $1.602B | 0.00 |
| AtriCure (ATRC) | United States | $1.581B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.366B | 19.78 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.321B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.082B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.039B | 308.29 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.873B | 0.00 |
| Valneva SE (VALN) | France | $0.863B | 0.00 |
| Omeros (OMER) | United States | $0.811B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.740B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 13.38 |
| Brainsway (BWAY) | Israel | $0.444B | 75.63 |
| Cerus (CERS) | United States | $0.417B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.410B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.380B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.347B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.310B | 24.73 |
| Evolus (EOLS) | United States | $0.277B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 18.31 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.201B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.190B | 56.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.77 |
| Vireo Growth (VREOF) | United States | $0.173B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.173B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.169B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.146B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.126B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.70 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.097B | 0.00 |
| Biote (BTMD) | United States | $0.095B | 4.18 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 28.92 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.33 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |